Publication

Article

Internal Medicine World Report

November 2014
Volume

Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome

Author(s):

Modifying diet is one way to try to help patients with Irritable Bowel Syndrome (IBS). In a study reported in Gastroenterology, an Australian research team looked at the effects of lowering fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) vs. consuming a typical Australian diet.

Modifying diet is one way to try to help patients with Irritable Bowel Syndrome (IBS). In a study reported in Gastroenterology, an Australian research team looked at the effects of lowering fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) vs. consuming a typical Australian diet.

The team found that the patients eating a low FODMAP diet experienced fewer IBS symptoms.

There were 30 IBS patients and 8 healthy individuals in the study group, randomly assigned to consume either a low FODMAP or typical Australian diet for 21 days. The meals were prepared by the team, frozen, prepackaged, and not labeled as to whether they were low-FODMAP. Each group that completed the 21-day diet then went through a 21-day washout period, then crossed over to the other diet.

Their symptoms were assessed both through stool analysis and breath samples — as well as interviews with the investigators.

The diet consisted of 3 main meals and 3 snacks daily. Participants were not calorie-restricted, but were allowed to eat according to their appetites.

“The results of this study provide high-quality evidence that the low FODMAP diet is efficacious for treatment of functional gastrointestinal symptoms in unselected IBS with symptoms being halved compared with a typical Australian diet,” Emma Halmos of Monash University and colleagues wrote in the article.

Related Videos
Christine Frissora, MD | Credit: Weill Cornell
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
© 2024 MJH Life Sciences

All rights reserved.